• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞培养物和痘苗病毒储备液的制备。

Preparation of Cell Cultures and Vaccinia Virus Stocks.

作者信息

Cotter Catherine A, Earl Patricia L, Wyatt Linda S, Moss Bernard

机构信息

National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland.

出版信息

Curr Protoc Microbiol. 2015 Nov 3;39:14A.3.1-14A.3.18. doi: 10.1002/9780471729259.mc14a03s39.

DOI:10.1002/9780471729259.mc14a03s39
PMID:26528781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5081219/
Abstract

The culturing of cell lines used with vaccinia virus, both as monolayer and in suspension, is described. The preparation of chick embryo fibroblasts (CEF) is presented for use in the production of the highly attenuated and host range-restricted modified vaccinia virus Ankara (MVA) strain of vaccinia virus. Protocols for the preparation, titration, and trypsinization of vaccinia virus stocks, as well as viral DNA preparation and virus purification methods are also included.

摘要

本文描述了用于痘苗病毒的细胞系在单层培养和悬浮培养中的培养方法。介绍了鸡胚成纤维细胞(CEF)的制备方法,用于生产高度减毒且宿主范围受限的痘苗病毒安卡拉改良株(MVA)。还包括痘苗病毒储备液的制备、滴定和胰蛋白酶消化方案,以及病毒DNA制备和病毒纯化方法。

相似文献

1
Preparation of Cell Cultures and Vaccinia Virus Stocks.细胞培养物和痘苗病毒储备液的制备。
Curr Protoc Microbiol. 2015 Nov 3;39:14A.3.1-14A.3.18. doi: 10.1002/9780471729259.mc14a03s39.
2
Preparation of Cell Cultures and Vaccinia Virus Stocks.细胞培养物和痘苗病毒储备液的制备。
Curr Protoc Protein Sci. 2017 Aug 1;89:5.12.1-5.12.18. doi: 10.1002/cpps.34.
3
Preparation of Cell Cultures and Vaccinia Virus Stocks.细胞培养物和痘苗病毒储备液的制备。
Curr Protoc Mol Biol. 2017 Jan 5;117:16.16.1-16.16.18. doi: 10.1002/cpmb.33.
4
Preparation of cell cultures and vaccinia virus stocks.细胞培养物和痘苗病毒储备液的制备。
Curr Protoc Mol Biol. 2001 May;Chapter 16:Unit16.16. doi: 10.1002/0471142727.mb1616s43.
5
Preparation of cell cultures and vaccinia virus stocks.细胞培养物和痘苗病毒储备液的制备。
Curr Protoc Protein Sci. 2001 May;Chapter 5:Unit5.12. doi: 10.1002/0471140864.ps0512s13.
6
Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.改良安卡拉痘苗病毒在原代鸡胚成纤维细胞中的复制需要干扰素抗性基因E3L的表达。
J Virol. 2003 Aug;77(15):8394-407. doi: 10.1128/jvi.77.15.8394-8407.2003.
7
Growth and Purification of Vaccinia Virus Stocks for MPM Imaging.用于MPM成像的痘苗病毒储备液的生长与纯化
Methods Mol Biol. 2019;2023:287-299. doi: 10.1007/978-1-4939-9593-6_18.
8
Easy and efficient protocols for working with recombinant vaccinia virus MVA.用于处理重组痘苗病毒MVA的简便高效方案。
Methods Mol Biol. 2012;890:59-92. doi: 10.1007/978-1-61779-876-4_4.
9
Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.将改良安卡拉痘苗病毒(MVA)的六大基因组缺失引入亲本痘苗病毒中,不足以在细胞培养和小鼠中再现类似 MVA 的表型。
J Virol. 2010 Oct;84(19):9907-19. doi: 10.1128/JVI.00756-10. Epub 2010 Jul 28.
10
The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.标记基因交换与荧光激活细胞分选相结合提高了人用重组改良安卡拉痘苗病毒疫苗生产的效率。
J Virol Methods. 2010 Feb;163(2):195-204. doi: 10.1016/j.jviromet.2009.09.016. Epub 2009 Sep 22.

引用本文的文献

1
Ciclopirox suppresses poxvirus replication by targeting iron metabolism.环吡酮通过靶向铁代谢来抑制痘病毒复制。
bioRxiv. 2025 Jul 24:2025.07.24.666650. doi: 10.1101/2025.07.24.666650.
2
Advancing ORFV-Based Therapeutics to the Clinical Stage.将基于羊口疮病毒的疗法推进到临床阶段。
Rev Med Virol. 2025 May;35(3):e70038. doi: 10.1002/rmv.70038.
3
Poxvirus structural biology for application to vaccine design.用于疫苗设计的痘病毒结构生物学
Trends Immunol. 2025 Jun;46(6):455-470. doi: 10.1016/j.it.2025.04.002. Epub 2025 May 7.
4
Severe malaria enforces short-lived effector cell differentiation but does not prevent effective secondary responses by memory CD8 T cells.重症疟疾促使短暂性效应细胞分化,但并不妨碍记忆性CD8 T细胞产生有效的二次应答。
PLoS Pathog. 2025 Mar 31;21(3):e1012993. doi: 10.1371/journal.ppat.1012993. eCollection 2025 Mar.
5
Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8 + T cell responses.基于多表位的甲型流感病毒交叉反应性CD8 + T细胞应答诱导疫苗的设计与评价
Sci Rep. 2025 Mar 27;15(1):10586. doi: 10.1038/s41598-025-95479-9.
6
Modified Vaccinia Virus Ankara Titration Using Crystal Violet- or Immuno-Staining in DF-1 Cells.在DF-1细胞中使用结晶紫或免疫染色法对改良安卡拉痘病毒进行滴定
Methods Mol Biol. 2025;2860:287-296. doi: 10.1007/978-1-0716-4160-6_19.
7
The Microbiome Modifies Manifestations of Hemophagocytic Lymphohistiocytosis in Perforin-Deficient Mice.微生物群改变穿孔素缺陷小鼠噬血细胞性淋巴组织细胞增生症的表现。
Eur J Immunol. 2025 Jan;55(1):e202451061. doi: 10.1002/eji.202451061. Epub 2024 Nov 16.
8
Stimulation of neutral lipid synthesis via viral growth factor signaling and ATP citrate lyase during vaccinia virus infection.在牛痘病毒感染过程中,通过病毒生长因子信号和三磷酸柠檬酸裂解酶刺激中性脂质合成。
J Virol. 2024 Nov 19;98(11):e0110324. doi: 10.1128/jvi.01103-24. Epub 2024 Oct 30.
9
A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow Cytometry.一种针对改良安卡拉痘苗病毒(MVA)包膜蛋白的新型单克隆抗体,可用于流式细胞术测定 MVA 病毒滴度。
Viruses. 2024 Oct 17;16(10):1628. doi: 10.3390/v16101628.
10
Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice.多价 MVA 载体疫苗在恒河猴中诱导 EBV 中和抗体,减少人源化小鼠中的 EBV 感染。
Front Immunol. 2024 Sep 13;15:1445209. doi: 10.3389/fimmu.2024.1445209. eCollection 2024.

本文引用的文献

1
Gene expression using the vaccinia virus/T7 RNA polymerase hybrid system.使用痘苗病毒/T7 RNA聚合酶杂交系统进行基因表达。
Curr Protoc Mol Biol. 2001 May;Chapter 16:Unit16.19. doi: 10.1002/0471142727.mb1619s43.
2
The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.改良安卡拉痘苗病毒株的全基因组序列:与其他正痘病毒的比较。
Virology. 1998 May 10;244(2):365-96. doi: 10.1006/viro.1998.9123.
3
Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.痘苗病毒高度减毒的MVA株的宿主范围和细胞致病性:在非人类哺乳动物细胞系中重组病毒的增殖与产生
Virology. 1997 Nov 24;238(2):198-211. doi: 10.1006/viro.1997.8845.
4
Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.高度减毒痘苗病毒MVA基因组中缺失区域的定位及其对毒力的影响。
J Gen Virol. 1991 May;72 ( Pt 5):1031-8. doi: 10.1099/0022-1317-72-5-1031.
5
Nonreplicating vaccinia vector efficiently expresses recombinant genes.非复制型痘苗病毒载体能高效表达重组基因。
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10847-51. doi: 10.1073/pnas.89.22.10847.